Rago L - Search Results

1

Twenty-five years of essential medicines.

Quick JD, Hogerzeil HV, Velasquez G, Rago L. Quick JD, et al. Among authors: rago l. Bull World Health Organ. 2002;80(11):913-4. Bull World Health Organ. 2002. PMID: 12481216 Free PMC article. No abstract available.

2

Access to essential medicines for children: the world health organization's global response.

Zucker H, Rägo L. Zucker H, et al. Among authors: rago l. Clin Pharmacol Ther. 2007 Nov;82(5):503-5. doi: 10.1038/sj.clpt.6100395. Clin Pharmacol Ther. 2007. PMID: 17952106

3

Review of quality deficiencies found in active pharmaceutical ingredient master files submitted to the WHO Prequalification of Medicines Programme.

Ortega Diego I, Fake A, Stahl M, Rägo L. Ortega Diego I, et al. Among authors: rago l. J Pharm Pharm Sci. 2014;17(2):169-86. doi: 10.18433/j3q60j. J Pharm Pharm Sci. 2014. PMID: 24934546 Review.

4

Essential medicines for universal health coverage.

Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR. Wirtz VJ, et al. Among authors: rago l. Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8. Lancet. 2017. PMID: 27832874 Free PMC article. Review. No abstract available.

5

Regulatory framework for access to safe, effective quality medicines.

Rägo L, Sillo H, 't Hoen E, Zweygarth M. Rägo L, et al. Antivir Ther. 2014;19 Suppl 3:69-77. doi: 10.3851/IMP2902. Epub 2014 Oct 13. Antivir Ther. 2014. PMID: 25310085 Review.

6

Promoting GMP implementation: developing training materials for the international audience.

Morimoto K, Curry J, Kopp S, Rägo L, van Zyl A, Wondemagegnehu E, Quick J, Suzuki Y. Morimoto K, et al. Among authors: rago l. Qual Assur. 2003;10(1):11-27. doi: 10.1080/10529410390198864. Qual Assur. 2003. PMID: 12746156

7

Boosting access to essential medicines for children.

Hogerzeil HV, Hill S, Rago L. Hogerzeil HV, et al. Among authors: rago l. Lancet. 2006 Oct 21;368(9545):1419. doi: 10.1016/S0140-6736(06)69603-7. Lancet. 2006. PMID: 17055942 No abstract available.

8

Prescribing information in 26 countries: a comparative study.

Reggi V, Balocco-Mattavelli R, Bonati M, Breton I, Figueras A, Jambert E, Kopp C, Montane E, Rägo L, Rocchi F; International Comparative Study on Drug Information Collaborative Group. Reggi V, et al. Among authors: rago l. Eur J Clin Pharmacol. 2003 Aug;59(4):263-70. doi: 10.1007/s00228-003-0607-1. Epub 2003 May 21. Eur J Clin Pharmacol. 2003. PMID: 12759794

9

The biowaiver procedure: its application to antituberculosis products in the WHO prequalification programme.

Strauch S, Jantratid E, Stahl M, Rägo L, Dressman JB. Strauch S, et al. Among authors: rago l. J Pharm Sci. 2011 Mar;100(3):822-30. doi: 10.1002/jps.22349. Epub 2010 Oct 6. J Pharm Sci. 2011. PMID: 20928870

10

Regulatory policy for research and development of vaccines for public health emergencies.

Kieny MP, Rägo L. Kieny MP, et al. Among authors: rago l. Expert Rev Vaccines. 2016 Sep;15(9):1075-7. doi: 10.1080/14760584.2016.1188695. Epub 2016 May 27. Expert Rev Vaccines. 2016. PMID: 27181597 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results